Medical Device Manufacturing Statistics 2026

Industry overview

The US medical device industry generates roughly $200 billion in annual revenue, accounting for about 40% of the global market. Major device categories span imaging equipment, cardiovascular devices, orthopedic implants, diagnostics, surgical instruments, in-vitro diagnostics, and consumables.

Top public companies anchor much of the visible market: Medtronic, Abbott, Stryker, Boston Scientific, Becton Dickinson, Edwards Lifesciences, GE HealthCare, Baxter, Zimmer Biomet, and Intuitive Surgical. Beyond the named primes, the supply base runs deep, with thousands of contract manufacturers, component suppliers, sterilization processors, and packaging specialists serving the regulated medical market.

Employment and wages

Medical device manufacturing pays well above the manufacturing average. AdvaMed reports the industry-wide average compensation at approximately $94,000 per year, reflecting the engineering-heavy workforce and the premium for regulated manufacturing experience.

Roles range from production technicians and quality engineers to design engineers, regulatory affairs specialists, and clinical liaisons. Demand for quality and regulatory talent remains structurally tight, with experienced regulatory professionals commanding $130,000 to $200,000 in major medtech clusters.

Top states by medical device employment

Medical device manufacturing concentrates around five major regional clusters: California (Bay Area, Orange County, San Diego), Massachusetts (Greater Boston), Minnesota (Twin Cities), Indiana (Warsaw orthopedic cluster), and Florida.

Sub-segments

The medical device industry splits across several major sub-segments, with cardiovascular, in-vitro diagnostics, orthopedics, and imaging equipment leading by revenue.

Regulatory framework

Every medical device manufacturer in the United States operates under the FDA Quality System Regulation (21 CFR Part 820) and most align their quality systems with ISO 13485. The framework is one of the most demanding in any manufacturing sector. Devices are classified into Class I, Class II, and Class III based on risk, with submission pathways ranging from simple 510(k) clearance for most Class II devices to Premarket Approval (PMA) for many Class III implants.

Contract manufacturers that serve the medtech industry typically hold ISO 13485 certification, maintain validated processes (IQ/OQ/PQ documentation), operate cleanroom environments where required (ISO 7 or ISO 8 most commonly), and run rigorous supplier qualification on their own upstream vendors.

What this means for medical device suppliers in 2026

Contract manufacturers, component suppliers, sterilization processors, packaging specialists, and validation consultants all compete for medtech work in 2026. Three trends shape the picture. First, OEMs continue consolidating their preferred supplier lists, favoring partners with broader scope and demonstrated quality systems. Second, FDA scrutiny on contract manufacturers has intensified following 2023 to 2024 quality enforcement actions, which raises the bar on supplier audits. Third, AI-driven supplier research is becoming common at the procurement and engineering levels, particularly for early-stage and mid-cap device companies that lack large sourcing teams.

Suppliers that publish detailed capability content on their websites, including specific ISO 13485 scope, cleanroom classes, validation experience, and example device categories, win disproportionate share of inbound consideration.